Ambrisentan Viatris

ambrisentan · Viatris Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ambrisentan Viatris, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: EMA Authorised: Ambrisentan Viatris (previously Ambrisentan Mylan) (ambrisentan) — Viatris Limited